Cargando…

Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis

The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Isha, Shah, Kalpit, Bradbury, Neil A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912/
https://www.ncbi.nlm.nih.gov/pubmed/27081574
http://dx.doi.org/10.4172/2157-7412.1000284
_version_ 1782426675047301120
author Dey, Isha
Shah, Kalpit
Bradbury, Neil A
author_facet Dey, Isha
Shah, Kalpit
Bradbury, Neil A
author_sort Dey, Isha
collection PubMed
description The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. In this short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientific support for their use as therapeutic agents in the treatment of patients with CF.
format Online
Article
Text
id pubmed-4828912
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-48289122016-04-12 Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis Dey, Isha Shah, Kalpit Bradbury, Neil A J Genet Syndr Gene Ther Article The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. In this short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientific support for their use as therapeutic agents in the treatment of patients with CF. 2016-01-30 2016-02 /pmc/articles/PMC4828912/ /pubmed/27081574 http://dx.doi.org/10.4172/2157-7412.1000284 Text en http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Dey, Isha
Shah, Kalpit
Bradbury, Neil A
Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title_full Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title_fullStr Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title_full_unstemmed Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title_short Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
title_sort natural compounds as therapeutic agents in the treatment cystic fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912/
https://www.ncbi.nlm.nih.gov/pubmed/27081574
http://dx.doi.org/10.4172/2157-7412.1000284
work_keys_str_mv AT deyisha naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis
AT shahkalpit naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis
AT bradburyneila naturalcompoundsastherapeuticagentsinthetreatmentcysticfibrosis